BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 55.52 -0.92 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.44 | 52 Week High | $108.96 | |||
| Open | $56.40 | 52 Week Low | $62.12 | |||
| Day High | $57.00 | P/E | N/A | |||
| Day Low | $55.51 | EPS | $-1.27 | |||
| Volume | 1,212,647 | |||||
